SeaSpine to Report Fourth Quarter 2020 Financial Results on March 1, 2021
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced it will release its fourth quarter financial results after market close on March 1, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SeaSpine Holdings Corporation (NASDAQ: SPNE) announced it will release its fourth quarter financial results after market close on March 1, 2021. The management team will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss these results. Interested participants can join by dialing (877) 418-4766 (domestic) or (614) 385-1253 (international) with Conference ID: 3485218. SeaSpine is a global medical technology firm specializing in surgical solutions for spinal disorders, providing a comprehensive portfolio of orthobiologics and spinal implants.
Positive
- Company plans to announce fourth quarter financial results, indicating active business operations.
Negative
- None.
Details
News Market Reaction – SPNE
The recorded move for SPNE in the trading session of this news was +2.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter financial results after the close of trading on Monday, March 1, 2021. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.
Individuals interested in listening to the conference call may do so by dialing (877) 418-4766 for domestic callers or (614) 385-1253 for international callers, using Conference ID: 3485218. To listen to a live webcast, please visit the Investors section of the SeaSpine website at: www.seaspine.com.
About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.
Investor Relations Contact
Leigh Salvo
(415) 937-5402
ir@seaspine.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.